These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 7433922)

  • 1. Dicloxacillin and flucloxacillin twice daily with probenecid in staphylococcal infections. A clinical and pharmakokinetic evaluation.
    Hedström SA; Kahlmeter G
    Scand J Infect Dis; 1980; 12(3):221-5. PubMed ID: 7433922
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of chronic staphylococcal osteomyelitis with cloxacillin and dicloxacillin--a comparative study in 12 patients.
    Hedström SA
    Scand J Infect Dis; 1975; 7(1):55-7. PubMed ID: 1145134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Should probenecid be used to reduce the dicloxacillin dosage in orthopaedic infections? A study of the dicloxacillin-saving effect of probenecid.
    Krogsgaard MR; Hansen BA; Slotsbjerg T; Jensen P
    Pharmacol Toxicol; 1994 Mar; 74(3):181-4. PubMed ID: 8008725
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Flucloxacillin treatment of methicillin-'resistant' and sensitive staphylococcal infection.
    Kidson A; Lilly HA; Lowbury EJ
    J Antimicrob Chemother; 1979 Jul; 5(4):359-64. PubMed ID: 489489
    [No Abstract]   [Full Text] [Related]  

  • 5. Dicloxacillin and flucloxacillin: pharmacokinetics, protein binding and serum bactericidal titers in healthy subjects after oral administration.
    Røder BL; Frimodt-Møller N; Espersen F; Rasmussen SN
    Infection; 1995; 23(2):107-12. PubMed ID: 7622258
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A comparative study of the efficacy, safety and tolerance of azithromycin, dicloxacillin and flucloxacillin in the treatment of children with acute skin and skin-structure infections.
    Rodriguez-Solares A; Pérez-Gutiérrez F; Prosperi J; Milgram E; Martin A
    J Antimicrob Chemother; 1993 Jun; 31 Suppl E():103-9. PubMed ID: 8396081
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Concentrations of cloxacillin, dicloxacillin and flucloxacillin in dental alveolar serum and mandibular bone.
    Köndell PA; Nord CE; Nordenram A
    Int J Oral Surg; 1982 Feb; 11(1):40-3. PubMed ID: 6811456
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Pharmacokinetic and clinical research on a new antibiotic combination (amoxicillin and flucloxacillin in equivalent-weight dose)].
    Di Nola F; Soranzo ML; Bosio G; Sachelariu N; Mastroviti S
    Minerva Med; 1977 Mar; 68(14):917-28. PubMed ID: 321992
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The activity of isoxazolyl penicillins in experimental staphylococcal infection.
    Renneberg J; Forsgren A
    J Infect Dis; 1989 Jun; 159(6):1128-32. PubMed ID: 2723456
    [No Abstract]   [Full Text] [Related]  

  • 10. [Clinical evaluation of flucloxacillin in the treatment of serious staphylococcal infections in children].
    Saied H; Ben Attia M
    J Int Med Res; 1986; 14(5):261-6. PubMed ID: 3770291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intravenous followed by oral antimicrobial therapy for staphylococcal endocarditis.
    Chayakul P; Yipintsoi T
    J Med Assoc Thai; 1993 Oct; 76(10):559-63. PubMed ID: 7964226
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Flucloxacillin in chronic leg ulcers. Penetration of flucloxacillin into chronic leg ulcer exudate and the effect on the bacteria.
    Stürup J; Sandberg Sørensen T; Slotsbjerg T; Hofmann B
    Acta Pathol Microbiol Immunol Scand B; 1987 Aug; 95(4):213-7. PubMed ID: 3673578
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum levels and clinical effect of flucloxacillin in patients with staphylococcal infections.
    Kamme C; Ursing B
    Scand J Infect Dis; 1974; 6(3):273-8. PubMed ID: 4608517
    [No Abstract]   [Full Text] [Related]  

  • 14. [Flucloxacillin].
    Mastroviti S; Cassarino G
    G Batteriol Virol Immunol; 1975; 68(7-12):279-88. PubMed ID: 1234594
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Early termination of a prospective, randomized trial comparing teicoplanin and flucloxacillin for treating severe staphylococcal infections.
    Calain P; Krause KH; Vaudaux P; Auckenthaler R; Lew D; Waldvogel F; Hirschel B
    J Infect Dis; 1987 Feb; 155(2):187-91. PubMed ID: 2949024
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The clinical efficacy of continuous-infusion flucloxacillin in serious staphylococcal sepsis.
    Leder K; Turnidge JD; Korman TM; Grayson ML
    J Antimicrob Chemother; 1999 Jan; 43(1):113-8. PubMed ID: 10381108
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Does Staphylococcus aureus acquire resistance to methicillin during beta-lactam therapy?
    Morris AJ; Lang SD
    N Z Med J; 1987 Aug; 100(829):504. PubMed ID: 3455524
    [No Abstract]   [Full Text] [Related]  

  • 18. The efficacy of the combination of teicoplanin or flucloxacillin with netilmicin in the treatment of Staphylococcus aureus bacteraemia.
    Degener JE; Vogel M; Michel MF; Mutsaers MM; Hop WC
    J Antimicrob Chemother; 1989 Jun; 23(6):899-904. PubMed ID: 2527224
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Experimental studies of amoxycillin-flucloxacillin combination.
    Ripa S; Prenna M; Vitali C
    Antibiotica; 1974 Jun; 12(2):88-106. PubMed ID: 4470369
    [No Abstract]   [Full Text] [Related]  

  • 20. Clinical evaluation of parenteral dicloxacillin.
    Deresinski SC; Stevens DA
    Curr Ther Res Clin Exp; 1975 Jul; 18(1 pt 2):151-62. PubMed ID: 809231
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.